Research Article

QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1

Table 1

UPLC-Q-TOF indicated metabolites and potential pathway analysis.

Number (min)VIP valueFormulaIndicated metabolitesPathway

(1)0.37175.02822.320.00001C6H8N2O2Methylimidazoleacetic acidHistidine metabolism
(2)0.64167.09382.90.0001C7H16AcetylcholineAcetylcholine synthesis
(3)1.31212.05492.020.0002C9H13NO6N2-Succinyl-L-glutamic acid 5-semialdehydeArginine and proline metabolism
(4)2.22498.30173.270.014C26H48NO7PLysoPC (18:3)Glycerophospholipid metabolism
(5)2.26514.29375.720.001C24H48NO7PLysoPC (16:1)Glycerophospholipid metabolism
(6)2.59860.60161.440.0001C47H88NO8PPE (24:0/18:3)Glycerophospholipid metabolism
(7)4.16619.46361.640.005C36H62O5DG (15:0/18:4/0:0)Diacylglycerol metabolize
(8)4.191138.43541.040.001C45H82N7O17P3STetracosanoyl-CoABiosynthesis of unsaturated fatty acids
(9)4.24500.29082.130.0001C23H48NO6PPC (P-15:0/0:0)Glycerophospholipid metabolism
(10)4.48660.24161.820.0002C30H45N3O9SLeukotriene C5Arachidonic acid metabolism
(11)4.7353.23452.260.0001C20H34O5Prostaglandin H1Prostaglandin synthesis and regulation
(12)4.82592.28891.890.0001C26H46NO9PPS (20:3/0:0)Glycerophospholipid metabolism
(13)4.87353.24611.290.0002C22H36O2Adrenic acidBiosynthesis of unsaturated fatty acids
(14)5.13583.32871.280.0001C27H53O11PPI (18:0/0:0)Glycerophospholipid metabolism
(15)7.3799.59521.240.004C43H83N2O6PSM (d18:0/20:2)Sphingolipid metabolism
(16)8.83129.00201.60.0001C5H8O3S2-Oxo-4-methylthio-butanoic acidMethionine metabolism
(17)11.27779.51891.250.0001C40H77NO11S3-O-Sulfogalactosylceramide (d18:1/16:0)Sphingolipid metabolism
(18)11.88479.24712.660.0001C24H40O6SLithocholic acid sulfateBiological oxidations
(19)13.44237.12661.140.06C19H26O2Dodecanoic acidFatty acid biosynthesis
(20)14.9595.37362.440.0003C19H26O2AndrostenedioneSteroid biosynthesis